Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma

Background: The predictive value of tumor-infiltrating lymphocytes (TILs) in immune-related adverse event (irAE) development remains unknown, although an association between tumor immunogenicity and irAEs has been suggested. We investigated the association between TIL abundance in pretreatment prima...

Full description

Bibliographic Details
Main Authors: I.A.J. van Duin, M. Schuiveling, L.S. ter Maat, M. Veta, M.J.M. van Eijs, R.J. Verheijden, F.W.P.J. van den Berkmortel, M.J. Boers-Sonderen, G.A.P. Hospers, M. Labots, J.W.B. de Groot, E. Kapiteijn, D. Piersma, G. Vreugdenhil, H. Westgeest, A.M.R. Schrader, P.J. van Diest, W.A.M. Blokx, K.P.M. Suijkerbuijk
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Immuno-Oncology and Technology
Subjects:
melanoma
immunotherapy
immune-related adverse events
pathology
tumor-infiltrating lymphocytes
Online Access:http://www.sciencedirect.com/science/article/pii/S259001882400011X

Internet

http://www.sciencedirect.com/science/article/pii/S259001882400011X

Similar Items